NCT00267670View on ClinicalTrials.gov

Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Nonalcoholic SteatohepatitisLiver Diseases
Interventions
DRUG

Pentoxifylline

400mg PO TID

DRUG

Placebo

1 pill PO TID

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT00267670 - Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH | Biotech Hunter | Biotech Hunter